[PERSON]
Julie Kim
Featured in 1 tracked story · first seen
Situations
FDA, Japan, and China approve Orzeyful for narcolepsy
4 clusters · 9 sources · last updated
Latest: Orzeyful receives global approvals for narcolepsy type 1 treatment
The U.S. Food and Drug Administration has approved Takeda’s Orzeyful (oveporexton), the first oral orexin-2 receptor agonist for adults with narcolepsy type 1. Unlike previous treatments that manage symptoms, Orzeyful ta